GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (BOM:532531) » Definitions » Issuance of Debt

Strides Pharma Science (BOM:532531) Issuance of Debt : ₹0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Strides Pharma Science Issuance of Debt?

Strides Pharma Science's Issuance of Debt for the three months ended in Dec. 2024 was ₹0 Mil.

Strides Pharma Science's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil.

Strides Pharma Science Issuance of Debt Historical Data

The historical data trend for Strides Pharma Science's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Strides Pharma Science Issuance of Debt Chart

Strides Pharma Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 686.12 5,674.58 9,070.89 3,304.00 3,497.64

Strides Pharma Science Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Strides Pharma Science Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strides Pharma Science Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Strides Pharma Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (BOM:532531) » Definitions » Issuance of Debt
Comparable Companies
BOM:543748 BOM:530549 BOM:531599 NSE:INNOVACAP BOM:524735 BOM:532872 BOM:506690 BOM:524372 BOM:544222 NSE:RPGLIFE ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
STAR:India
Address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076
Website
https://www.strides.com
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market plan focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. The company's reportable segment are; Pharmaceutical & Bio-pharmaceutical.

Strides Pharma Science Headlines

No Headlines